The present invention relates to a pharmaceutical composition for preventing or treating liver cancer and a method for producing same, the composition comprising tetraarsenic hexoxide in which the content of tetraarsenic hexoxide crystalline polymorph a (As.sub.4O.sub.6-a) is 99% or more. The composition of the present invention exhibits an excellent cancer cell proliferation inhibition effect and thus can be useful as an anticancer drug.

Disclosed is a plurality of metal chalcogenide nanocrystals coated with multiple organic and inorganic ligands; wherein the metal is selected from Hg, Pb, Sn, Cd, Bi, Sb or a mixture thereof; and the chalcogen is selected from S, Se, Te or a mixture thereof; wherein the multiple inorganic ligands includes at least one inorganic ligands are selected from S.sup.2, HS.sup., Se.sup.2, Te.sup.2, OH.sup., BF.sub.4.sup., PF.sub.6.sup., Cl.sup., Br.sup., I.sup., As.sub.2Se.sub.3, Sb.sub.2S.sub.3, Sb.sub.2Te.sub.3, Sb.sub.2Se.sub.3, As.sub.2S.sub.3 or a mixture thereof; and wherein the absorption of the CH bonds of the organic ligands relative to the absorption of metal chalcogenide nanocrystals is lower than 50%, preferably lower than 20%.

The present invention relates to the field of nanotechnology, more specifically to the manufacture or treatment of nanostructures, and in particular provides arsenic sulfide nanostructures, as well as a process for obtaining nanostructures of arsenic sulfide. The present invention provides a process for obtaining arsenic sulfide (AsS) nanostructures from a microorganism, which comprises the steps of culturing under appropriate conditions the strain Fusibacter ascotence in the presence of a source of sulfur and a source of arsenic; and recovering arsenic sulfide nanostructures (AsS) from the precipitate obtained from said culture. The present invention provides, also, a nanostructure of arsenic sulfide which is a nanowire having a monoclinic crystal structure. The present invention further provides a nanostructure of arsenic sulfide, which is a nanoparticle with a monoclinic crystal structure.

Disclosed is a plurality of metal chalcogenide nanocrystals coated with multiple organic and inorganic ligands; wherein the metal is selected from Hg, Pb, Sn, Cd, Bi, Sb or a mixture thereof; and the chalcogen is selected from S, Se, Te or a mixture thereof; wherein the multiple inorganic ligands includes at least one inorganic ligands are selected from S.sup.2, HS.sup., Se.sup.2, Te.sup.2, OH.sup., BF.sub.4.sup., PF.sub.6.sup., Cl.sup., Br.sup., I.sup., As.sub.2Se.sub.3, Sb.sub.2S.sub.3, Sb.sub.2Te.sub.3, Sb.sub.2Se.sub.3, As.sub.2S.sub.3 or a mixture thereof; and wherein the absorption of the CH bonds of the organic ligands relative to the absorption of metal chalcogenide nanocrystals is lower than 50%, preferably lower than 20%.

The present invention relates to a pharmaceutical composition for preventing or treating liver cancer and a method for producing same, the composition comprising tetraarsenic hexoxide in which the content of tetraarsenic hexoxide crystalline polymorph a (As.sub.4O.sub.6-a) is 99% or more. The composition of the present invention exhibits an excellent cancer cell proliferation inhibition effect and thus can be useful as an anticancer drug.

The present invention relates to the field of nanotechnology, more specifically to the manufacture or treatment of nanostructures, and in particular provides arsenic sulfide nanostructures, as well as a process for obtaining nanostructures of arsenic sulfide.

The present invention provides a process for obtaining arsenic sulfide (AsS) nanostructures from a microorganism, which comprises the steps of culturing under appropriate conditions the strain Fusibacter ascotence in the presence of a source of sulfur and a source of arsenic; and recovering arsenic sulfide nanostructures (AsS) from the precipitate obtained from said culture.

The present invention provides, also, a nanostructure of arsenic sulfide which is a nanowire having a monoclinic crystal structure. The present invention further provides a nanostructure of arsenic sulfide, which is a nanoparticle with a monoclinic crystal structure.

A method for separating arsenic and heavy metals in an acidic washing solution which contains both arsenic and heavy metal, more particularly in a washing solution which is formed in copper smelting and contains sulphuric acid, comprises a separation process section, in which arsenic and at least one primary heavy metal are separated from one another. The separation process section comprises a processing step, in which hydrogen peroxide H2O2 is added to the washing solution, and the separation process section comprises a precipitation stage, in which the washing solution is admixed with a sulphide precipitation reagent, causing the at least one primary heavy metal to precipitate in the form of a metal sulphide. The processing step in this system is carried out before the precipitation stage.

Provided are an intelligent decision-making and control method and system for a microchemical reaction in stepwise sulfidation of a high arsenic-contained waste acid from copper smelter. Microchemical information from the real-time monitoring module is acquired by the intelligent decision-making module. A stage combination for a sulfidation reaction is determined based on a concentration of arsenic in raw waste acid. A total amount of arsenic and an amount of hydrogen sulfide to be added at a first stage are calculated based on a valence state and concentration of arsenic in and a flow rate of inflow at the first stage, and a total amount of arsenic and an amount of hydrogen sulfide to be added at a second stage are calculated based on a valence state and concentration of arsenic in and a flow rate of inflow at the second stage.